Literature DB >> 22466123

Interaction and regulatory functions of μ- and δ-opioid receptors in nociceptive afferent neurons.

Xu Zhang1, Lan Bao.   

Abstract

μ-opioid receptor (MOR) agonists such as morphine are powerful analgesics used for pain therapy. However, the use of these drugs is limited by their side-effects, which include antinociceptive tolerance and dependence. Earlier studies reported that MOR analgesic tolerance is reduced by blockade of δ-opioid receptors (DORs) that interact with MORs. Recent studies show that the MOR/DOR interaction in nociceptive afferent neurons in the dorsal root ganglion may contribute to morphine analgesic tolerance. Further analysis of the mechanisms for regulating the trafficking of receptors, ion channels and signaling molecules in nociceptive afferent neurons would help to understand the nociceptive mechanisms and improve pain therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466123      PMCID: PMC5560394          DOI: 10.1007/s12264-012-1206-x

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  95 in total

1.  Post-activation-mediated changes in opioid receptors detected by N-terminal antibodies.

Authors:  Achla Gupta; Raphael Rozenfeld; Ivone Gomes; Kirsten M Raehal; Fabien M Décaillot; Laura M Bohn; Lakshmi A Devi
Journal:  J Biol Chem       Date:  2008-02-06       Impact factor: 5.157

2.  Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord.

Authors:  U Arvidsson; M Riedl; S Chakrabarti; J H Lee; A H Nakano; R J Dado; H H Loh; P Y Law; M W Wessendorf; R Elde
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

3.  Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord.

Authors:  P Y Cheng; A L Svingos; H Wang; C L Clarke; S Jenab; I W Beczkowska; C E Inturrisi; V M Pickel
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

4.  Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.

Authors:  Claire Gaveriaux-Ruff; Chihiro Nozaki; Xavier Nadal; Xavier C Hever; Raphael Weibel; Audrey Matifas; David Reiss; Dominique Filliol; Mohammed A Nassar; John N Wood; Rafael Maldonado; Brigitte L Kieffer
Journal:  Pain       Date:  2011-02-03       Impact factor: 6.961

5.  Follistatin-like 1 suppresses sensory afferent transmission by activating Na+,K+-ATPase.

Authors:  Kai-Cheng Li; Fang-Xiong Zhang; Chang-Lin Li; Feng Wang; Ming-Yan Yu; Yan-Qing Zhong; Kai-Hua Zhang; Ying-Jin Lu; Qiong Wang; Xiao-Li Ma; Jun-Ru Yao; Jin-Yuan Wang; Li-Bo Lin; Mei Han; Yu-Qiu Zhang; Rohini Kuner; Hua-Sheng Xiao; Lan Bao; Xiang Gao; Xu Zhang
Journal:  Neuron       Date:  2011-03-10       Impact factor: 17.173

6.  Transport of receptors, receptor signaling complexes and ion channels via neuropeptide-secretory vesicles.

Authors:  Bo Zhao; Hai-Bo Wang; Ying-Jin Lu; Jian-Wen Hu; Lan Bao; Xu Zhang
Journal:  Cell Res       Date:  2011-02-15       Impact factor: 25.617

7.  Dissociation of μ- and δ-opioid inhibition of glutamatergic synaptic transmission in superficial dorsal horn.

Authors:  Paul J Wrigley; Hyo-Jin Jeong; Christopher W Vaughan
Journal:  Mol Pain       Date:  2010-10-26       Impact factor: 3.395

8.  Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia.

Authors:  Françoise Mennicken; Ji Zhang; Cyrla Hoffert; Sultan Ahmad; Alain Beaudet; Dajan O'Donnell
Journal:  J Comp Neurol       Date:  2003-10-20       Impact factor: 3.215

Review 9.  Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.

Authors:  Laxmaiah Manchikanti; Angelie Singh
Journal:  Pain Physician       Date:  2008-03       Impact factor: 4.965

10.  Short elements with charged amino acids form clusters to sort protachykinin into large dense-core vesicles.

Authors:  Guo-Qiang Ma; Bin Wang; Hai-Bo Wang; Qiong Wang; Lan Bao
Journal:  Traffic       Date:  2008-10-22       Impact factor: 6.215

View more
  7 in total

1.  Recent progress in understanding the mechanisms of pain and itch.

Authors:  Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2012-04       Impact factor: 5.203

Review 2.  Opioid receptor trafficking and interaction in nociceptors.

Authors:  X Zhang; L Bao; S Li
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 3.  Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.

Authors:  Wakako Fujita; Ivone Gomes; Lakshmi A Devi
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

4.  Peripheral G protein-coupled inwardly rectifying potassium channels are involved in δ-opioid receptor-mediated anti-hyperalgesia in rat masseter muscle.

Authors:  M-K Chung; Y S Cho; Y C Bae; J Lee; X Zhang; J Y Ro
Journal:  Eur J Pain       Date:  2013-06-06       Impact factor: 3.931

Review 5.  Opioid receptors: toward separation of analgesic from undesirable effects.

Authors:  Ping-Yee Law; Patricia H Reggio; Horace H Loh
Journal:  Trends Biochem Sci       Date:  2013-04-16       Impact factor: 13.807

Review 6.  Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function.

Authors:  Ivone Gomes; Achla Gupta; Ittai Bushlin; Lakshmi A Devi
Journal:  Front Pharmacol       Date:  2014-12-03       Impact factor: 5.810

7.  Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide.

Authors:  Yin Yang; Qian Li; Qi-Hua He; Ji-Sheng Han; Li Su; You Wan
Journal:  Exp Mol Med       Date:  2018-05-21       Impact factor: 8.718

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.